News | June 01, 2021
Shilpa Medicare Q4FY21 consolidated PAT at Rs. 7.82 Cr
The company has posted net profit of Rs.147.78 crores for the 12 months period ended March 31, 2021
The company has posted net profit of Rs.147.78 crores for the 12 months period ended March 31, 2021
The company reported total income of Rs.24774.63 crores during the 12 months period ended March 31, 2021
The company has posted net profit of Rs.1140.01 crores during FY 2020-21
It posted net profit of Rs.60.96 crores for the 12 months period ended March 31, 2021
Dr. Sharvil Patel cites the example of prescriptions being handed over to patients despite unavailability of enough stock of such medicines
Cadila Healthcare has reported total income of Rs.15139.4 crores FY 2020-21
Strides Pharma Science reported total income of Rs.3367.29 crores during FY 2020-21
Revenue from operations for the year ended March 31, 2021 is ?2,239 crore
The turnover of its NPNC Formulations Division (IKKT Undertaking) for FY 2020-2021 is Rs.21.33 Cr
The company has reported total income of Rs.826.40 crores for FY 2020-21
Subscribe To Our Newsletter & Stay Updated
